Debbie Ryan
About Debbie Ryan
Debbie Ryan is the Director of Medical Strategy at both Bristol Myers Squibb and Mirati Therapeutics, with over 25 years of experience in medical affairs and oncology.
Current Role and Responsibilities
Debbie Ryan currently holds the position of Director, Medical Strategy at both Bristol Myers Squibb and Mirati Therapeutics. At Bristol Myers Squibb, she works remotely, while her role at Mirati Therapeutics is based in Chicago, Illinois. Her responsibilities in these roles likely involve developing and implementing medical strategies, managing clinical trials, and collaborating with healthcare professionals to promote oncological treatments.
Previous Experience at AstraZeneca
Debbie Ryan has an extensive history with AstraZeneca, having worked in various capacities over a cumulative span of 19 years. Her roles included Medical Director for five months in 2022, Director of Medical Diagnostics in US Oncology Medical Affairs from 2020 to 2022, and Executive Oncology Medical Science Liaison from 2015 to 2020. She also served as a Medical Science Liaison and Product Development Scientist from 1998 to 2010. These roles involved responsibilities ranging from medical diagnostics to oncology medical affairs and science liaison activities.
Experience at Boehringer Ingelheim
Debbie Ryan served as the Senior Medical Science Liaison in the oncology sector at Boehringer Ingelheim from 2010 to 2014, focusing on oncology. In this senior role, she contributed her expertise to various medical science liaison activities, working closely with research and development teams to further oncology treatments.
Educational Background
Debbie Ryan has a robust educational background, having studied at North Carolina State University and Trinity University. These academic qualifications underpin her extensive experience and expertise in the medical affairs and oncology fields.
Over 25 Years of Experience in Medical Affairs and Oncology
Debbie Ryan brings over 25 years of experience in the medical affairs and oncology fields. Her lengthy career has seen her contribute to various organizations, including AstraZeneca and Boehringer Ingelheim, where she has been involved in roles such as medical diagnostics, oncology medical affairs, and medical science liaison. This extensive experience highlights her depth of knowledge and expertise in the field of oncology.